서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 381 to 392 of 392

Issue DateTitle / Author(s) / CitationFileAltmetrics
2008-05
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
DOI
2015-06
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
DOI
2001-04
A phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies
DOI
2021-01
A novel immune prognostic index for stratification of high-risk patients with early breast cancer
DOI
2003-10
A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells
DOI
2014-07
A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions
DOI
2004-11
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2019-08
A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors
DOI
2022-07
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro)
DOI
2004-12
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma
DOI
2005-04
[6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin
DOI
2011-09
17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy
DOI
115 16 17 18 19 20